Clinical Trial Update: Raltegravir and Ezetimibe PK Study [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated the interaction between raltegravir and ezetimibe in HIV-infected participants; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Raltegravir (raltegravir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 1 | Status: COMPLETED